These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38369474)

  • 1. Correction: Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.
    Su Z; Zhang Y; Cao J; Sun Y; Cai Y; Zhang B; He L; Zhang Z; Xie J; Meng Q; Luo L; Li F; Li J; Zhang J; Chen X; Hong A
    J Nanobiotechnology; 2024 Feb; 22(1):70. PubMed ID: 38369474
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.
    Su Z; Zhang Y; Cao J; Sun Y; Cai Y; Zhang B; He L; Zhang Z; Xie J; Meng Q; Luo L; Li F; Li J; Zhang J; Chen X; Hong A
    J Nanobiotechnology; 2023 Feb; 21(1):55. PubMed ID: 36803994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF2 and FGFR2 in patients with idiopathic pulmonary fibrosis and lung cancer.
    Li L; Zhang S; Wei L; Wang Z; Ma W; Liu F; Qian Y
    Oncol Lett; 2018 Aug; 16(2):2490-2494. PubMed ID: 30013642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration.
    Czaplinska D; Turczyk L; Grudowska A; Mieszkowska M; Lipinska AD; Skladanowski AC; Zaczek AJ; Romanska HM; Sadej R
    Biochim Biophys Acta; 2014 Nov; 1843(11):2461-70. PubMed ID: 25014166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
    Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
    Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing.
    Sterner E; Masuko S; Li G; Li L; Green DE; Otto NJ; Xu Y; DeAngelis PL; Liu J; Dordick JS; Linhardt RJ
    J Biol Chem; 2014 Apr; 289(14):9754-65. PubMed ID: 24563485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-acne agents attenuate FGFR2 signal transduction in acne.
    Melnik BC; Schmitz G; Zouboulis CC
    J Invest Dermatol; 2009 Aug; 129(8):1868-77. PubMed ID: 19225542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR2 signaling and the pathogenesis of acne.
    Melnik B; Schmitz G
    J Dtsch Dermatol Ges; 2008 Sep; 6(9):721-8. PubMed ID: 19000061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia.
    Tian C; Li Y; Wang L; Si J; Zheng Y; Kang J; Wang Y; You MJ; Zheng G
    Cell Death Dis; 2022 Nov; 13(11):922. PubMed ID: 36333298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Comedones, Acne, and Hidradenitis Suppurativa in a Patient with an
    Higgins R; Pink A; Hunger R; Yawalkar N; Navarini AA
    Front Med (Lausanne); 2017; 4():16. PubMed ID: 28293556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2.
    Iseki S; Wilkie AO; Heath JK; Ishimaru T; Eto K; Morriss-Kay GM
    Development; 1997 Sep; 124(17):3375-84. PubMed ID: 9310332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current research on hyaluronic acid-drug bioconjugates.
    Zhang H; Huang S; Yang X; Zhai G
    Eur J Med Chem; 2014 Oct; 86():310-7. PubMed ID: 25173850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2.
    Zhang Y; Ouyang M; Wang H; Zhang B; Guang W; Liu R; Li X; Shih TC; Li Z; Cao J; Meng Q; Su Z; Ye J; Liu F; Hong A; Chen X
    MedComm (2020); 2020 Dec; 1(3):362-375. PubMed ID: 34766128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of Therapeutic Efficacy and Safety of Microneedling Alone Versus Microneedling with Hyaluronic Acid in Post-Acne Scarring.
    Bano R; Brar BK; Kumar S
    J Cutan Aesthet Surg; 2023; 16(4):279-285. PubMed ID: 38314374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of FGF2 to FGFR2 in an autocrine mode in trophectoderm cells is indispensable for mouse blastocyst formation through PKC-p38 pathway.
    Yang J; Zhang D; Yu Y; Zhang RJ; Hu XL; Huang HF; Lu YC
    Cell Cycle; 2015; 14(20):3318-30. PubMed ID: 26378412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
    Lilli C; Bellucci C; Baroni T; Aisa C; Carinci P; Scapoli L; Carinci F; Pezzetti F; Lumare E; Stabellini G; Bodo M
    Cytokine; 2007 Apr; 38(1):22-31. PubMed ID: 17537644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined autologous platelet-rich plasma with microneedling versus microneedling with non-cross-linked hyaluronic acid in the treatment of atrophic acne scars: Split-face study.
    Amer A; Elhariry S; Al-Balat W
    Dermatol Ther; 2021 Jan; 34(1):e14457. PubMed ID: 33107665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
    Ibrahimi OA; Eliseenkova AV; Plotnikov AN; Yu K; Ornitz DM; Mohammadi M
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7182-7. PubMed ID: 11390973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.
    Fan L; Li W; Ying S; Shi L; Wang Z; Chen G; Ye H; Wu X; Wu J; Liang G; Li X
    Tumour Biol; 2015 Sep; 36(9):7233-41. PubMed ID: 25894376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.